TABLE 1.
Hemostasis laboratory markers in patients with COVID‐19
| Management of coagulopathy | Therapeutic management | Observed derangements | ||
|---|---|---|---|---|
| Decreased | Increased | Increased | Equivocal | |
| D‐dimers | Anti‐Xa | FVIII | aPTT | |
| PT (sec) | VWF | AT | ||
| Platelet count | Clot formation in TEG | PC | ||
| Fibrinogen | PS | |||
| Fibrinolysis parameters | ||||
| aPL | ||||
Abbreviations: aPL, antiphospholipid antibodies; aPTT, activated partial thromboplastin time; AT, antithrombin; FVIII, factor VIII; PC, protein C; PS, protein S; PT, prothrombin time; TEG, thromboelastography; VWF, von Willebrand factor.